News & Topics

Jul 31, 2018

A Business Partnership with Beckman Coulter Regarding Urine Analysis Systems in the U.S.

ARKRAY, Inc.(Head office: Kamigyo-ku, Kyoto, President & CEO: Takeshi Matsuda)is pleased to announce that U.S. ARKRAY, a wholly owned US subsidiary of ARKRAY, Inc. (Head office: Minneapolis, Minnesota, President: Kosuke Nakanishi), has entered a contract with Beckman Coulter Inc.(Head office: Brea, California, President: Chris Riley)for a business partnership on urine analysis systems in the U.S.

ARKRAY, Inc's. (hereunder, ARKRAY) subsidiary U.S. ARKRAY, Inc. and Beckman Coulter Inc.(hereunder, Beckman Coulter)have signed a contract for a business partnership in the U.S. and for the sale of urine analysis systems.

ARKRAY's fully automated urine analyzer "AUTION MAX AX-4030" will be paired to Beckman Coulter's urine sediment analyzer "iQ200 Digital Flow Morphology" and sold in the U.S. from the end of July 2018 as the "iQ Workcell".
This system will be exhibited at the 70th AACC 2018(The American Association for Clinical Chemistry" (July 29 to August 2, 2018, Chicago).

Through this partnership of our two companies, ARKRAY hopes to streamline laboratory workflow for the U.S. urine analysis market and contribute to a reduction of labor and cost while continuing to respond to customer needs, elevating our presence and expanding our business in the U.S. market.

About Beckman Coulter Inc.

Beckman Coulter is a global company based in California which is expanding its business in 120 countries. For over 80 years, they have been a leader in the field of in-vitro diagnostics.

About U.S. ARKRAY, Inc.

U.S. ARKRAY, Inc. is a wholly owned subsidiary of ARKRAY, Inc. and was established in 2010 as the American branch of ARKRAY, Inc. U.S. ARKRAY, Inc. mainly provides diabetes testing and urinalysis systems.

About ARKRAY's businesses in the Americas

ARKRAY has 4 subsidiaries in the U.S., including U.S. ARKRAY, Inc. These subsidiaries provide diabetes testing systems and urine analysis systems to medical institutions in North, Central and South America while also providing self monitoring blood glucose devices through drug store chains and other retailers.